Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Celldex Therapeutics (CLDX)

3.34 -0.04 (-1.18%)

4/27/2017  12:26pm

Open:

3.40

Pre. Close:

3.38

High:

3.41

Low:

3.33

Volume:

308,600

Market Cap:

411.53M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

3.46 - 3.52

3.52 - 3.58

Low:

3.15 - 3.2

3.2 - 3.24

Close:

3.29 - 3.39

3.39 - 3.48

Technical analysis  (as of: 2017-04-27 12:28:46 PM)

Overall:

      

Stoxline posted a BUY today, downgraded from strong buy. But this stock still is very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 4.12     One year: 4.38

Support:

Support1: 3.16    Support2: 2.63

Resistance:

Resistance1: 3.52    Resistance2: 3.75

Pivot:

3.28

Moving Averages:

MA(5): 3.29     MA(20): 3.33

MA(100): 3.49     MA(250): 3.84

MACD:

MACD(12,26): -0.03     Signal(12,26,9): -0.04

%K %D:

%K(14,3): 63.43     %D(3): 41.72

RSI:

RSI(14): 50.56

52-Week:

High: 5.13  Low: 2.85  Change(%): -16.5

Average Vol(K):

3-Month: 1814  10-Days 1352

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CLDX has closed below upper band by 14.8%. Bollinger Bands are 70.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to CLDX's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 28 Feb 2017 12:22:30 GMT
Better Buy: Celldex Therapeutics, Inc. vs. Juno Therapeutics Inc

Wed, 26 Apr 2017 13:52:30 GMT
Stock inside Traders Spotlight: Celldex Therapeutics, Inc. (CLDX)

Wed, 26 Apr 2017 18:56:15 GMT
Today Analysts Focus on Celldex Therapeutics, Inc. (CLDX), Fifth Street ...

Mon, 24 Apr 2017 16:41:15 GMT
Meditor Group Ltd Buys Celldex Therapeutics, Sells VIVUS

Tue, 25 Apr 2017 19:07:30 GMT
Lookout for Price Target? InvenSense, Inc. (INVN), Celldex Therapeutics, Inc ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

123.21

Shares Float (M)

115.51

% Held by Insiders

0.54

% Held by Institutions

89.20

Shares Short (K)

19820

Shares Short Prior Month (K)

19190

Stock Financials

EPS

-1.270

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

2.200

PEG Ratio

Profit Margin

Operating Margin

-1895.31

Return on Assets (ttm)

-22.3

Return on Equity (ttm)

-46.3

Qtrly Rev. Growth

4.6

Gross Profit (p.s.)

0.055

Sales Per Share

0.055

EBITDA (p.s.)

-1.011

Qtrly Earnings Growth

Operating Cash Flow (M)

-113.04

Levered Free Cash Flow (M)

-59.49

FoxReading.com

Valuation

P/E

-2.63

P/E Growth Ratio

-0.01

P/BV

1.52

P/S

60.61

P/CF

-3.64

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

0.083

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.